Intensive Monitoring of Adverse Drug Reactions in Patients Receiving Pharmacological Treatments for Rheumatoid Arthritis and Other Rheumatologic Diseases, with Particular Focus on Biotechnological Drugs: The ASTRAGALUS Study / M. Tuccori;G. Glustarini;L. Bazzichi;S. Manganelli;F. Peruzzi;O. M. Sacu;L. Picchianti;A. Capogrosso;M. Rossi;F. Sernissi;C. Glacomelli;R. Neri;M. G. De;F. Nacci;F. Lapi;C. Scollo;S. Mantarro;S. Montagnani;L. Sabadini;A. Testi;E. Ruggiero;A. Vannacci;A. Mugelli;S. Bombardieri;M. M. Cerinic;M. Galeazzi;C. Blandizzi. - In: DRUG SAFETY. - ISSN 0114-5916. - STAMPA. - 34:(2011), pp. 984-985.
Intensive Monitoring of Adverse Drug Reactions in Patients Receiving Pharmacological Treatments for Rheumatoid Arthritis and Other Rheumatologic Diseases, with Particular Focus on Biotechnological Drugs: The ASTRAGALUS Study
LAPI, FRANCESCO;VANNACCI, ALFREDO;MUGELLI, ALESSANDRO;M. M. Cerinic;
2011
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.